These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 15503695)

  • 1. Using the written description requirement to limit broad patent scope, allow competition, and encourage innovation in biotechnology.
    Mull WC
    Health Matrix Clevel; 2004; 14(2):393-435. PubMed ID: 15503695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of federal circuit discrimination: the evolution of the written description requirement vis-a-vis DNA and biotechnological inventions concerns for synthetic biology.
    Greenbaum D
    Recent Pat DNA Gene Seq; 2011 Dec; 5(3):153-65. PubMed ID: 21787273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of the evolution of the written description requirement vis-à-vis DNA and biotechnological inventions.
    Greenbaum D
    Recent Pat DNA Gene Seq; 2007; 1(2):138-44. PubMed ID: 19075928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The written description rejection as a barrier to biotech patent prosecution.
    Wang SJ
    Hum Vaccin; 2011 May; 7(5):569-73. PubMed ID: 21552000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patenting nanotechnology.
    Lemley MA
    Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Must an inventor "possess" an invention to patent it?
    Woessner WD; Chadwick RA
    Cold Spring Harb Perspect Med; 2014 Sep; 4(11):a020867. PubMed ID: 25237144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inventions and Patents: A Practical Tutorial.
    Mehta H; Tidwell L; Liotta LA
    Methods Mol Biol; 2017; 1606():379-397. PubMed ID: 28502014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
    Jannuzzi AH; Vasconcellos AG; de Souza CG
    Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design-around biotechnology patents: an analysis of US Federal Circuit decisions shows the possibility of designing around biotechnology patents.
    Wang SJ
    Hum Vaccin; 2011 Jan; 7(1):125-8. PubMed ID: 21263222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basics of US patents and the patent system.
    Elliott G
    AAPS J; 2007 Aug; 9(3):E317-24. PubMed ID: 17915834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is your reasonable expectation of success in obtaining pharmaceutical or biotechnology patents having nonobvious claimed inventions that the courts will uphold? An overview of obviousness court decisions.
    Pereira DJ; Kunin SG
    Cold Spring Harb Perspect Med; 2014 Dec; 5(4):. PubMed ID: 25475106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovations and intellectual property: the case of genomic patenting.
    Jackson BA
    J Policy Anal Manage; 2003; 22(1):5-25. PubMed ID: 12722760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patentability and maximum protection of intellectual property in proteomics and genomics.
    Warburg RJ; Wellman A; Buck TB; Ligler Schoenhard A
    Pharmacogenomics; 2003 Jan; 4(1):81-90. PubMed ID: 12517288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent protection for Aspergillus-related inventions.
    Jong SC; Birmingham JM
    Biotechnology; 1992; 23():297-311. PubMed ID: 1504603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intellectual property protection of plant biotechnology inventions.
    Sechley KA; Schroeder H
    Trends Biotechnol; 2002 Nov; 20(11):456-61. PubMed ID: 12413819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of America Invents Act on Biotech Intellectual Property.
    Murphy A; Stramiello M; Stroud J; Lewis S; Irving T
    Cold Spring Harb Perspect Med; 2015 Apr; 5(9):a020784. PubMed ID: 25918182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for strengthening patent protection of pharmaceutical inventions in light of federal court decisions.
    Pillai X; Kinney WA
    Curr Top Med Chem; 2010; 10(18):1929-36. PubMed ID: 20615184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act.
    Colaianni A; Cook-Deegan R
    Milbank Q; 2009 Sep; 87(3):683-715. PubMed ID: 19751286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.
    Abbot J
    J Law Med; 2006 Aug; 14(1):110-26. PubMed ID: 16937785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.